

Broadcom Up Ahead of Earnings, Moderna Higher, Disney Slides on Layoffs
Jun 2, 2025
Broadcom is on the rise as it heads toward an earnings report, with analysts optimistic about AI-driven growth. In a significant move, Moderna's stock has climbed after getting FDA approval for its second-generation COVID vaccine. Meanwhile, Disney is struggling, with shares dropping following announcements of layoffs across its film and TV divisions, highlighting Hollywood's ongoing challenges. These developments are indicative of broader trends in tech and entertainment sectors, sparking investor interest.
AI Snips
Chapters
Transcript
Episode notes
Broadcom's AI Boost
- Broadcom stock rose over 3% ahead of earnings driven by optimism in its AI software strength.
- Analysts foresee better quarterly results and guidance despite potential margin pressure from ramping AI chip production.
Broadcom as a Cheaper AI Bet
- An analyst favors Broadcom over NVIDIA, citing better value for AI investment.
- Broadcom is seen as a cheaper AI play yet remains central to the AI theme.
Moderna's New Vaccine Approval
- Moderna gained FDA approval for its next-gen Covid vaccine for adults over 65 and at-risk people over 12.
- Despite approval, uncertainty remains due to public skepticism from FDA leadership about vaccines.